The typical course of HIV infection for a majority of untreated individuals is persistent viral replication and a gradual loss of CD4 + T cells. One of the consequences of ongoing HIV replication is increased immune activation, aff ecting all major cell populations of the immune system ( 1 -3 ). Within the B cell population, HIV infection has been associated with numerous perturbations ( 4 ), many of which have been attributed to changes in the distribution of B cell subpopulations found in the peripheral blood. These changes include increased frequencies of activated and terminally diff erentiated B cells expressing low levels of CD21 that have been associated with ongoing viral replication ( 5, 6 ), a decreased frequency of memory B cells that is not reversed by antiretroviral therapy ( 7 ), and an increased frequency of immature/transitional B cells that has been associated with CD4 + T cell lymphopenia ( 8, 9 ).
BRIEF DEFINITIVE REPORT
The typical course of HIV infection for a majority of untreated individuals is persistent viral replication and a gradual loss of CD4 + T cells. One of the consequences of ongoing HIV replication is increased immune activation, aff ecting all major cell populations of the immune system ( 1 -3 ). Within the B cell population, HIV infection has been associated with numerous perturbations ( 4 ), many of which have been attributed to changes in the distribution of B cell subpopulations found in the peripheral blood. These changes include increased frequencies of activated and terminally diff erentiated B cells expressing low levels of CD21 that have been associated with ongoing viral replication ( 5, 6 ), a decreased frequency of memory B cells that is not reversed by antiretroviral therapy ( 7 ) , and an increased frequency of immature/transitional B cells that has been associated with CD4 + T cell lymphopenia ( 8, 9 ) .
The eff ects of immune activation in persistent viral infections have recently been shown to include virus-specifi c T cell exhaustion. After the original description in chronic lymphocyte choriomeningitis virus (LCMV) infection in mice ( 10 ) , observations of virus-specifi c CD4 + and CD8 + T cell exhaustion have recently been extended to HIV-viremic individuals ( 11, 12 ) . Although PD-1 was the fi rst inhibitory receptor associated with virus-specifi c T cell exhaustion, recent fi ndings suggest that exhaustion may result in the blood of HIV-viremic individuals. Furthermore, we fi nd that HIV-specifi c B cells are enriched within this B cell subpopulation that exhibits many properties associated with virus-specifi c exhaustion. We thus provide evidence for HIVassociated exhaustion in the B cell compartment that may, in part, explain the inadequacy of the anti-HIV antibody response in HIV-infected individuals ( 16 ) .
RESULTS AND DISCUSSION
Low expression of CD21 on peripheral blood B cells of HIVinfected individuals identifi es distinct B cell subpopulations that are associated with HIV viremia and lymphopenia ( 5, 6, 8, 9 ) . We previously demonstrated that immature/transitional B cells (CD10 + /CD27 Ϫ ) account for a fraction of CD21 lo B from the combined eff ect of increased expression of multiple inhibitory receptors ( 13, 14 ) .
The recent characterization of the inhibitory receptor Fcreceptor-like-4 (FCRL4), expressed on a unique subpopulation of memory B cells in human tonsillar tissues, led to the suggestion of an immunoregulatory role for this receptor ( 15 ) . The phenotypic features of these tissue memory B cells included increased expression of CD20 and reduced expression of CD21 and CD27. Given that reduced expression of CD21 on peripheral blood B cells is associated with ongoing HIV replication ( 5, 6 ), we sought to further investigate the nature of CD21 lo B cells in HIV-viremic individuals. We observed that tissuelike CD21 lo memory B cells expressing high levels of FCRL4 and other inhibitory receptors circulate , and other inhibitory/homing receptors and adhesion molecules (E) on CD20 hi /CD27 Ϫ /CD21 lo tissuelike memory (black), CD27 + classical memory (blue), and CD20 int /CD27 Ϫ /CD21 hi naive (red) B cells. MFI, mean fl uorescence intensity. All stains included CD19, which was used to establish the B cell gate. Immature/transitional B cells were excluded by performing stains on CD10-depleted B cells or on PBMCs gated on CD19 + /CD10 Ϫ cells.
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subpopulations are responsible for the FCRL4 expression with in the CD27 + B cell compartment ( Fig. 1 C and not depicted). However, for clarity and consistency with the functional data in the following paragraphs, B cells expressing CD27 are henceforth collectively referred to as classical memory B cells.
In addition to FCRL4, tissuelike memory B cells in the blood of HIV-viremic individuals expressed relatively high levels of other potentially inhibitory receptors ( 17, 18 ) , including CD22, CD85j, CD85k, LAIR-1, and CD72 ( Fig. 1 E and Table I ). Levels of FCRL4, CD22, and CD85j were signifi cantly higher on tissuelike memory compared with classical memory and naive B cells, whereas the expression of other inhibitory receptors on tissuelike memory B cells was similar or intermediate to that of either naive or classical memory B cells ( Table I ) . Furthermore, these tissuelike memory B cells in the blood expressed a profi le of traffi cking receptors similar to that described for tonsillar tissue memory B cells ( 15 ) Table I ). CXCR3, CD11c, and CCR6 were expressed at signifi cantly higher levels, whereas CCR7, CD62L, and CXCR5 were expressed at significantly lower levels on tissuelike memory compared with both classical memory and naive B cells ( Table I ) . Expression of CXCR4 was signifi cantly lower on both tissuelike and classical memory compared with naive B cells ( Table I ) . Collectively, tissuelike memory B cells in the blood of HIV-viremic individuals express high levels of inhibitory receptors and a profi le of traffi cking receptors that is consistent with migration to chronically infl amed tissues and away from lymphoid tissues that favor B -T cell interactions ( 20 -23 ) . Of note, increased expression of multiple inhibitory receptors and alterations in the expression cells in CD4 + T cell -lymphopenic individuals ( 8, 9 ) , whereas plasmablasts (CD20 Ϫ ) account for another fraction of CD21 lo B cells in HIV-viremic individuals ( Fig. 1 A ) ( 5, 6 ) . Few of these B cells are present in the peripheral blood of HIV-aviremic and HIV-negative individuals (Fig. S1 , available at http://www .jem.org/cgi/content/full/jem.20072683/DC1). However, aside from plasmablasts and immature/transitional B cells, we observed another population of CD21 lo B cells in the peripheral blood of HIV-viremic individuals; these CD21 lo B cells express high levels of CD20 and low-to-intermediate levels of CD27 ( Fig. 1 A ) . Such a profi le is similar to that of tonsillar tissue memory B cells, defi ned by the expression of the inhibitory receptor FCRL4 ( 15 ) .
To further characterize the peripheral blood-derived CD20 hi /CD27 Ϫ /CD21 lo B cells of HIV-viremic individuals, which comprise a median of 19% of B cells compared with < 4% in HIV-aviremic and -negative individuals, we measured cell surface expression of FCRL4. Peripheral blood mature B cells of HIV-viremic individuals expressed signifi cantly higher levels of FCRL4 compared with B cells of HIV-aviremic and -negative individuals ( Fig. 1 B ) . The term mature B cells, applied here and throughout the manuscript, is used to indicate that CD10 + immature/transitional B cells, which do not express FCRL4 (not depicted), were excluded from this study. In HIV-viremic individuals, FCRL4 expression was increased on tissuelike memory B cells, defi ned here by the expression profi le CD20 hi /CD27 Ϫ /CD21 lo , compared with classical memory (CD27 + ) and naive (CD20 int /CD27 Ϫ /CD21 hi ) B cells ( Fig. 1 , C and D, and Table I ). Of note and illustrated in Fig. 1 A and C , CD27 + B cells of HIV-viremic individuals are comprised of resting memory (CD20 int /CD27 int /CD21 hi ), activated memory B cells (CD20 hi /CD27 int /CD21 lo ), and plasmablasts (CD20 Ϫ /CD27 hi /CD21 lo ) ( 5, 6 ). The latter two ber of cell divisions a B cell has undergone after exiting the bone marrow. Initially, we validated the assay on several welldefi ned B cell subpopulations that were sorted from the peripheral blood of HIV-viremic individuals. The number of cell divisions was lowest in immature/transitional B cells, followed by an increasing number in naive; tissuelike memory; resting memory; activated memory; and fi nally in plasmablasts, which underwent the highest number of cell divisions ( The number of cell divisions that tissuelike memory B cells underwent was signifi cantly lower than that of classical memory B cells and signifi cantly higher than that of naive B cells ( Fig. 2 B ) . In addition, we evaluated the degree of somatic hypermutation in each fraction using a restriction enzyme -based hotspot assay that measures Ig VH3 diversity ( 8, 24, 25 ) . Similar to the KREC assay, the Ig VH3 diversity assay was performed on the three B cell subpopulations illustrated in Fig. 1 C , and the results for one representative individual are depicted in Fig. 2 C . The median Ig VH3 diversity index of tissuelike memory B cells was signifi cantly lower and higher compared with that of classical memory and naive B cells, respectively ( Fig. 2 D ) . Collectively, these data suggest that the tissuelike memory B cells found in the blood of HIV-viremic individuals have reached a stage of diff erentiation and a degree of somatic hypermutation that are intermediate to those of naive and classical memory B cells. Next, we evaluated the proliferative capacities of each B cell fraction. Tissuelike memory B cells proliferated significantly less than naive B cells in response to B cell receptor (BCR) triggering and CD4 + T cell help (CD40 ligand; CD40L), and/or Toll-like receptor (TLR) 9-triggering with type B synthetic CpG oligodeoxynucleotides (CpG-B). Proliferative defi ciencies in tissuelike memory B cells were not as extensive when compared with classical memory B cells, especially in the presence of all three stimuli ( Fig. 3 A ) , suggesting that inhibitory pressures on tissuelike memory B cells may be overridden. Of note, we have demonstrated that classical memory B cells of HIV-viremic individuals are themselves deficient, especially in response to BCR and CD40 triggering, when compared with classical memory B cells of HIV-aviremic and HIV-negative individuals ( 6, 26 ) . This defi ciency in proliferation was explained in part by the presence of CD20 Ϫ plasmablasts among classical memory B cells of HIV-viremic individuals ( Fig. 1 C ) . Analysis of CFSE-labeled cells indicated that the majority of plasmablasts were shortlived ex vivo, regardless of culture conditions (not depicted). Furthermore, in the presence of B cell stimulatory cytokines IL-2 and -10 and CD40L, tissuelike memory and naive B cells proliferated at signifi cantly lower levels compared with classical memory B cells, whereas BCR triggering increased the proliferation of naive, but not tissuelike, memory B cells to levels similar to those observed for classical memory B cells ( Fig. 3 B ) . These latter data contrasted with those reported of homing receptors CXCR3, CD11c, CCR7, and CD62L similar to those described here are signatures of virus-specifi c CD8 + T cell exhaustion in chronic LCMV infection ( 13 ) . Given that exhaustion of virus-specifi c T cells similar to that observed in LCMV has been described in HIV-viremic individuals ( 11, 12 ) , we considered that exhaustion could also be occurring in HIV-specifi c B cells.
To further investigate the hypothesis of B cell exhaustion in HIV infection, we fractionated peripheral blood mature B cells from HIV-viremic individuals into CD27 + classical memory, CD27 Ϫ /CD21 lo tissuelike memory, and CD27 Ϫ / CD21 hi naive B cells. First, we evaluated the in vivo replication history of each fraction using a recently described PCRbased assay for measuring -deletion recombination excision circles (KRECs) ( 24 ) . Given that these circles, which are generated during the fi nal stages of Ig gene rearrangements in the bone marrow, become diluted by a factor of two each time a B cell divides, this approach provides an estimate of the num- each fraction after polyclonal stimulation ex vivo. Of note, these culture conditions, whereas unfavorable to the shortlived plasmablasts that are responsible for the spontaneous secretion of Igs in HIV disease (not depicted) (for review see [ 4 ] ), are required for the induction of ASCs from all other B cell subpopulations. Total Ig ASC frequencies were significantly higher in classical memory compared with tissuelike memory and naive B cells ( Fig. 4 A ) . There was no diff erence in total Ig ASC frequencies between tissuelike memory and naive B cells ( Fig. 4 A ) . However, as one would predict, frequencies of IgM ASCs were signifi cantly higher than IgG/A ASCs in the naive B cell fraction ( Fig. 4 B ; P = 0.002), whereas there was no diff erence between isotypes in the tissuelike memory B cell fraction ( Fig. 4 B ) . Also as expected, frequencies of IgG/A ASCs were signifi cantly higher than IgM ASCs in the classical memory B cell fraction ( Fig. 4 B ; for tonsil-derived FCRL4 + B cells, which responded robustly to IL-2 and -10 ( 15 ). This diff erence may be explained by the presence of IL-2/-10 -responsive CD27 + B cells among the tonsil-derived FCRL4 + , but not among our blood-derived tissuelike memory B cells ( Fig. 3 B ) ( 15 ) . Nonetheless, these data indicate that tissuelike memory B cells found in the blood of HIV-viremic individuals exhibit proliferative deficiencies when compared with naive and classical memory B cells. The low proliferative capacity of these B cells may be caused by the overexpression of inhibitory receptors, which is consistent with their reduced replication history in vivo ( Fig. 2, A and B ) . These data are also consistent with the low proliferative capacity that has been shown for exhausted HIVspecifi c T cells in HIV-viremic individuals ( 11, 12 ) .
Next, we measured frequencies of antibody-secreting B cells (ASCs), including total Ig and antigen-specifi c ASCs, in There were no differences between IgG/A and IgM ASC frequencies against HIV within fractions ( Fig. 4 F ) , except for naive B cells (IgG/A > IgM; P = 0.004). The reason for this diff erence is unclear, but may be explained by the presence of recently described IgG + /CD21 + /CD27 Ϫ memory B cells in this fraction ( 27 ) , or by HIV-induced in vivo priming of CD21 + B cells ( 28, 29 ) , leading to preferential expansion and class switching ex vivo. Nonetheless, these data clearly indicate that although total Ig and recall antigen ASCs were most prominent in classical memory B cells, HIV-specifi c ASCs were enriched in tissuelike memory B cells.
We previously demonstrated that CD21 lo B cells of HIVviremic individuals expressed increased levels of markers of activation, turnover, and differentiation, including CD80, CD86, CD95, Ki-67, and CD38 ( 6 ) . Phenotypic analyses of the three subpopulations investigated in the current study demonstrated that the CD21 lo B cells within the classical, P = 0.02). Collectively, these data indicate that tissuelike memory B cells fall between naive and classical memory B cells with regard to the extent of class switching. These data are consistent with the levels of somatic hypermutation shown in Fig. 2 (C and D) .
Finally, we measured ASC frequencies against the HIV envelope gp120 and infl uenza hemagglutinin, a recall antigen chosen for its widespread representation in our HIV-infected cohort as a result of annual vaccination campaigns. As expected, the frequency of infl uenza-specifi c ASCs was signifi cantly higher in classical memory B cells compared with tissuelike memory and naive B cells ( Fig. 4 C ) . There were no diff erences between IgG/A and IgM ASC frequencies against infl uenza within fractions ( Fig. 4 D ) . When the HIV response was evaluated, a signifi cantly higher frequency of HIV-specifi c ASCs was observed in tissuelike memory B cells compared with classical memory and naive B cells ( Fig. 4 E ) . 
isolated from PBMCs by negative magnetic bead -based selection using a B cell enrichment cocktail that was supplemented with tetrameric anti-CD10 mAb (StemCell Technologies). This approach excluded immature/transitional B cells, which are overrepresented in HIV-infected individuals with active disease ( 8 ) , and would have confounded the results in the current study. Phenotypic analyses were performed with anti -human mAbs mostly obtained from BD Biosciences, with the following exceptions: anti -human CD21 was obtained from Beckman Coulter; anti -human CD85j, CD85k, CXCR3, CCR6, CCR7, CXCR4, and CXCR5 were obtained from R & D Systems; anti -human CD11c was obtained from Invitrogen; and anti -human FCRL4 was obtained from M.D. Cooper (Emory Univeristy School of Medicine. Atlanta, GA) ( 15 ), and its secondary was anti -mouse IgG2a (Invitrogen). FACS analyses were performed on a FACSCalibur fl ow cytometer (BD Biosciences) using FlowJo software (Tree Star, Inc.).
B cell fractionation. Mature B cells were separated into CD27 + , CD27 Ϫ / CD21 hi , and CD27 Ϫ /CD21 lo fractions using a two-step magnetic beadbased selection process. Cells were fi rst fractionated by CD27 with biotinylated anti-CD27 (BioLegend), followed by anti-biotin Microbeads (Miltenyi Biotech), and recovery of fractions according to manufacturer specifi cations. Purities of CD27 + and CD27 Ϫ fractions were typically > 85% and > 95%, respectively. The CD27 Ϫ fraction was further fractionated with anti -CD21-FITC, followed by anti-FITC Microbeads (Miltenyi Biotech), and recovered according to manufacturer specifi cations. Purities after CD21 fractionation were typically > 85%. Alternatively, in some individuals where fractions were only to be used for molecular analyses, fractionation was done by cell sorting on a FACSAria instrument (BD Biosciences). Mature B cells were fractionated with anti -CD20-FITC (BD Biosciences) for plasmablast analyses and with anti -CD21-biotin (Ancell) for CFSE-based analyses, each followed by appropriate Microbead-based selection.
KREC assay.
The ratio of KREC joints (signal joint) to the J -C recombination genomic joints (coding joint) was determined as previously described ( 24 ) . In brief, genomic DNA was isolated from each B cell fraction by lysing cell pellets in 10 mM Tris-HCl, pH 8.0, containing 100 μ g/ml proteinase K (Roche), incubating for 1 h at 56 ° C, and heat inactivating the enzyme at 95 ° C for 10 min. Two separate PCR reactions were performed on ‫ف‬ 50 ng DNA each (based on the approximation of 6 pg DNA per cell), one reaction to amplify the signal joint and the other to amplify the coding joint, as previously detailed ( 24 ) . The number of cell divisions was calculated by subtracting the cycle threshold of the PCR detecting the coding joint from that of the PCR detecting the signal joint.
Somatic hypermutation analysis.
A restriction enzyme-based hotspot assay was used to evaluate Ig VH3 diversifi cation as previously described ( 25 ), with recently described modifi cations ( 8 ) . In brief, cell pellets from B cell fractions were lysed in RNA buff er (RNeasy; QIAGEN) and the RNA was reverse transcribed with a JH consensus reverse primer. The cDNA was amplifi ed with a Cy5-labeled VH3 consensus forward primer and the JH consensus reverse primer. The PCR products were digested with Alu I and separated on a polyacrylamide gel, and band intensities were measured using a PhosphorImager (Molecular Dynamics). The Ig VH3 diversity index was defi ned as the ratio of uncut PCR product in the presence of Alu I to uncut PCR product in the absence of Alu I.
Proliferation assay. This assay was performed as previously described ( 5 ) . In brief, cells were plated at 1 × 10 5 cells per well of a 96-well fl at-bottom plate with various combinations of the following reagents: 20 U/ml IL-2 (Roche); 100 ng/ml IL-10 (R & D Systems); 10 μ g/ml goat anti -human IgG/A/M (Jackson ImmunoResearch Laboratories); 500 ng/ml CD40 ligand ( 5 ); and phosphorothiolated CpG oligodeoxynucleotide type B (CpG-B; 2.5 μ g/ml; Operon). Cells were incubated for 72 h and pulsed for 16 h with tritiated thymidine. Proliferation was also assessed by FACS analysis of cells labeled with CFSE (Invitrogen).
but not tissuelike, memory B cells were largely responsible for these increases (Table SI and SII, available at http://www .jem.org/cgi/content/full/jem.20072683/DC1). Of note, plasmablasts, which represent a median of 5.5% of B cells in the peripheral blood of HIV-viremic individuals, expressed the highest levels of CD86, Ki-67, and CD38 (Table SII) . Collectively, our current and previous fi ndings demonstrate heterogeneous eff ects of HIV disease on B cells. These include lymphopenia associated with the appearance in blood of immature/transitional B cells ( 8, 9 ) , and increased cell turnover/ activation/diff erentiation (CD27 + /CD21 lo B cells) and exhaustion (CD27 Ϫ /CD21 lo B cells) associated with viremia.
In summary, we provide evidence for HIV-associated B cell exhaustion during HIV viremia. We have identifi ed a unique population of tissuelike memory B cells in the blood of HIVviremic individuals that are enriched with HIV-specifi c B cells and bear several of the same features that have been associated with virus-induced exhaustion of T cells ( 10 -14 ) . Evidence of exhaustion include increased expression of multiple inhibitory receptors; altered expression of homing receptors; reduced proliferative potential; and stunted replication history and Ig diversity. Alternatively, these stunted features may refl ect reduced CD4 + T cell help and other factors required for productive B cell responses, and/or overriding eff ects of increased inhibitory receptor expression. Given that overexpression of FCRL4 on tissuelike and, to a lesser extent, classical memory B cells in the blood is a feature unique to HIV infection, it is tempting to speculate that FCRL4 is key to the inhibitory properties suggested by our fi ndings. However, FCRL4 remains a putative inhibitory receptor with no known ligand. Furthermore, it is conceivable that it is the overall increase in multiple inhibitory receptors on tissuelike memory B cells that may contribute to their premature exhaustion, as has been discussed for exhausted LCMV-specifi c CD8 + T cells ( 13 ) . Without better tools to analyze virus-specifi c B cells at the single-cell level, many of these concepts regarding dysfunction of B cells by exhaustion will remain somewhat speculative. Nonetheless, our fi ndings suggest that HIV-specifi c responses are enriched in a compartment of tissuelike memory B cells in HIV-viremic individuals that exhibit many features of premature exhaustion. These fi ndings may help explain in part the relatively ineff ective HIV-specifi c antibody response in viremic, infected individuals.
MATERIALS AND METHODS
Study subjects. Leukapheresis and blood draw products were obtained from study subjects. We recruited 40 untreated HIV-viremic individuals (median plasma viremia: 18,606 [range 106 -264,747] copies HIV RNA/ml), 12 antiretroviral-treated HIV-aviremic individuals (plasma viremia < 50 copies HIV RNA per ml), and 12 HIV-negative individuals. HIV plasma viremia was measured by branched DNA assay (Bayer Diagnostics), with a lower limit of detection of 50 copies per ml. All study subjects provided informed consent, in accordance with the Institutional Review Board of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Phenotypic analysis. Peripheral blood mononuclear cells (PBMCs) were obtained by density-gradient centrifugation. Mature (CD10 Ϫ ) B cells were ELISpot assay. HIV-viremic individuals who were likely to have a B cell response to the infl uenza vaccine formulation of 2006 -2007, either from vaccination or natural infl uenza infection, were selected for this assay. The ELISPOT assays were performed as previously described ( 30 ) , with the following modifi cations. Each B cell fraction was plated at 1 -2 × 10 6 cells/well in 24-well plates and incubated in the presence of 1/10,000 Staphylococcus aureus Cowan (EMD Biosciences) and 2.5 μ g/ml CpG-B. 96-well nitrocellulose fi ltration plates (MAHAS45; Millipore) were coated overnight at 4 ° C with the following: 5 μ g/ml each anti -human and anti -human (Rockland); 5 μ g/ml ancestral HIV gp120 ( 31 ); 5 μ g/ml infl uenza vaccine formulation for 2006 -2007 (Sanofi-Pasteur); and 5 μ g/ml keyhole limpet hemocyanin control antigen (EMD Calbiochem). The HIV gp120 protein was produced and purifi ed as previously described ( 32 ) . Wells were blocked with RPMI containing 5% FCS for 2 h at room temperature before use. At day 4, cells were collected, counted, and transferred to coated plates at two diff erent dilutions, ranging from 3,000 -300,000 cells/well depending on the coating antigen or antibody. Cells were incubated at 37 ° C for 5 h, after which plates were washed and incubated overnight at 4 ° C with biotinylated anti -human IgG (1:20,000; Jackson), IgA (1:5,000; BD Biosciences), or IgM (1:5,000; BD Biosciences). Plates were washed, incubated with substrate (ELISpot Blue; R & D Systems), dried, and spots were enumerated with an automated Immunospot Series 3A analyzer and software (Cellular Technology). The number of antigen-specifi c spots was adjusted for background by subtracting spots in the keyhole limpet hemocyanin wells from those in the test wells and adjusting for the number of input cells. All washes were performed with PBS containing 0.25% Tween-20 (PBS-T) and anti -human Igs were diluted in PBS-T containing 1% FCS. For analyses of spontaneous antibody secretion, freshly isolated cells were plated directly onto antigencoated plates, as previously described ( 30 ) .
Statistical analyses. The three groups of individuals ( Fig. 1 B ) were compared simultaneously using the Kruskall-Wallis test, which, if significant at level 0.05, prompted pairwise comparisons by Wilcoxon rank sum tests. This approach of predicating pairwise comparisons on a signifi cant result for the simultaneous test provides strong control of the family-wise error rate when there are three comparisons. B cell subpopulations ( Table I ;  Table S1; and Table S2 ; Fig. 1 D ; Fig. 2 , B and D ; Fig. 3 ; and Fig. 4 , A, C, and E ) were compared simultaneously by the Friedman test which, if signifi cant, prompted pairwise comparisons by Wilcoxon signed rank tests. Comparisons between switched and unswitched immunoglobulin isotypes ( Fig. 4 , B, D, and F ) were made by Wilcoxon signed rank tests.
Online supplemental material. Fig. S1 shows the B cell subpopulations that are present in the peripheral blood of HIV-aviremic and -negative individuals. Fig. S2 shows the replicative histories of various B cell sub populations isolated from the peripheral blood of two HIV-viremic individuals. Tables S1 and S2 depict diff erences in the expression of activation markers and Ki-67 on and in the various B cell subpopulations, with Table S1 comparing expression between classical memory, tissuelike memory, and naive B cells and Table S2 comparing expression within subpopu lations of the classical memory B cell compartment. The online version of this article is available at http://www.jem.org/cgi/content/full/jem.20072683/DC1.
